Posted by Michael Wonder on 04 Nov 2022
Health Canada expands Tresiba (insulin degludec injection) label with efficacy and safety for use in pregnant women with diabetes
3 November 2022 - Tresiba, Canada's leading basal insulin, now approved for use during pregnancy.
Today, Novo Nordisk Canada announced that Health Canada has approved an update to the label for Tresiba (insulin degludec injection) for use in pregnant women with diabetes.
